ZEAL:CPH
Zealand Pharma A/S
238,00 DKK
arrow_upward
+0,42%(+1,00) 1 d
9 oct, 17:00:00 GMT+2 · DKK
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de ZEAL...
Abrir
240,00 DKK
Alto
241,70 DKK
Bajo
236,00 DKK
Cap. burs.
16,97 mil M
Vol. medio
412,72 mil
Volumen
293,77 mil
Máximo en 52 sem.
556,00 DKK
Mínimo en 52 sem.
233,50 DKK
Acciones en circulación
71,61 M
N.º de empleados
578
Abrir
240,00 DKK
Alto
241,70 DKK
Bajo
236,00 DKK
Cap. burs.
16,97 mil M
Vol. medio
412,72 mil
Volumen
293,77 mil
Máximo en 52 sem.
556,00 DKK
Mínimo en 52 sem.
233,50 DKK
Acciones en circulación
71,61 M
N.º de empleados
578
Noticias
De fuentes web y partners de noticias
MedWatch
·
hace 13 horas
Zealand CEO still backs “crown jewel” petrelintide despite another share slide
TipRanks
·
hace 2 días
Zealand Pharma Advances Petrelintide Into Phase III, Raising Its Profile in the Obesity Drug Race
TipRanks
·
hace 2 días
Petrelintide Phase III Trial Puts Zealand Pharma in the Obesity–Heart Disease Spotlight
TipRanks
·
hace 4 semanas
Petrelintide Phase III Trial Puts Zealand Pharma in the Weight-Loss Spotlight
Perfil
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
Acerca de Zealand Pharma A/S